• Home
  • About Us
  • Investment Approach
  • Portfolio
  • Impact
  • Team
  • News & Media
  • Contact
  • Home
  • About Us
  • Investment Approach
  • Portfolio
  • Impact
  • Team
  • News & Media
  • Contact
•Bysomerse_wp-capital
•InNews
•Tag:Globela, Pharma
•0

Somerset invests in Gujarat-based bulk drug firm in first pharma bet

Somerset Indus Capital Partners > News > Somerset invests in Gujarat-based bulk drug firm in first pharma bet
0Shares
GlobelaPharma

Recent News

GenWorks Health raises Rs 135 Cr from Somerset Indus Capital Partners, Morgan Stanley, Evolvence & Wipro GE
May 5, 2022Bysomerse_wp-capital
Food Fortification – An Innovative Solution to Overcome Malnutrition
March 7, 2022Bysomerse_wp-capital
Webinar: Industry Applications of Artificial Intelligence | Council SME | InterraIT
February 15, 2022Bysomerse_wp-capital

Tag Cloud

Apex Browndove Cygnus Diagnostics Digital Health EICU Express Fund Genworks Globela Healthcare Delivery Hexagon Hospitals IPO Krsnaa Medical devices Medtech Nutrition Pharma Prognosys Sandor Somerset Wellness

Recent Cases

Previous PostTHE NEXT OPPORTUNITY IN HEALTHCARE IS SPELT ‘TECHNOLOGY’Next PostGlobela Pharma – A Somerset Portfolio Company

Related Posts

November 16, 2021

Globela Pharma – A Somerset Portfolio Company

Bysomerse_wp-capitalInNews0

Leave a Reply Cancel Reply

Address

Somerset Healthcare Investment Advisors Pvt. Ltd.
401, 4th Floor, Pharma Search House,
72/73, Worli Hill Estate, Dr. B. G. Kher Road,
Worli, Mumbai 400 018

Media Centre

  • News

QUICK MENU

  • Contact Us
  • ESG & Impact
  • Investment philosophy
  • Team
  • Terms of Disclosure

Newsletter

© 2020 Somerset Healthcare Investment Advisors Pvt. Ltd. All Rights Reserved.